Susman Robert Graham
SEC Form 4 insider trading activity
Susman Robert Graham has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: May 1, 2026.
On the most recent filing, Susman Robert Graham is listed as Director at Immunovant, Inc. Inside the rolling window, Susman Robert Graham reported no open-market purchases and 1 open-market sale totaling $68K in IMVT.
Companies traded
Other insiders at IMVT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$68K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Susman Robert Graham made?
Susman Robert Graham has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Susman Robert Graham trade?
Susman Robert Graham has filed SEC Form 4 disclosures for 1 company, including IMVT.
When was Susman Robert Graham's most recent SEC Form 4 filing?
Susman Robert Graham's most recent SEC Form 4 filing on Tracefour is dated May 1, 2026.
What is Susman Robert Graham's total buy and sell value in the current window?
Inside the rolling retention window, Susman Robert Graham bought $0 and sold $68K based on SEC Form 4 filings.
What was Susman Robert Graham's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,502 IMVT shares on 2026-05-01, worth $68K, per SEC Form 4 filings.